Literature DB >> 10493583

Functional analyses of AmpC beta-lactamase through differential stability.

B M Beadle1, S L McGovern, A Patera, B K Shoichet.   

Abstract

Despite decades of intense study, the complementarity of beta-lactams for beta-lactamases and penicillin binding proteins is poorly understood. For most of these enzymes, beta-lactam binding involves rapid formation of a covalent intermediate. This makes measuring the equilibrium between bound and free beta-lactam difficult, effectively precluding measurement of the interaction energy between the ligand and the enzyme. Here, we explore the energetic complementarity of beta-lactams for the beta-lactamase AmpC through reversible denaturation of adducts of the enzyme with beta-lactams. AmpC from Escherichia coli was reversibly denatured by temperature in a two-state manner with a temperature of melting (Tm) of 54.6 degrees C and a van't Hoff enthalpy of unfolding (deltaH(VH)) of 182 kcal/mol. Solvent denaturation gave a Gibbs free energy of unfolding in the absence of denaturant (deltaG(u)H2O) of 14.0 kcal/mol. Ligand binding perturbed the stability of the enzyme. The penicillin cloxacillin stabilized AmpC by 3.2 kcal/mol (deltaTm = +5.8 degrees C); the monobactam aztreonam stabilized the enzyme by 2.7 kcal/mol (deltaTm = +4.9 degrees C). Both acylating inhibitors complement the active site. Surprisingly, the oxacephem moxalactam and the carbapenem imipenem both destabilized AmpC, by 1.8 kcal/mol (deltaTm = -3.2 degrees C) and 0.7 kcal/mol (deltaTm = -1.2 degrees C), respectively. These beta-lactams, which share nonhydrogen substituents in the 6(7)alpha position of the beta-lactam ring, make unfavorable noncovalent interactions with the enzyme. Complexes of AmpC with transition state analog inhibitors were also reversibly denatured; both benzo(b)thiophene-2-boronic acid (BZBTH2B) and p-nitrophenyl phenylphosphonate (PNPP) stabilized AmpC. Finally, a catalytically inactive mutant of AmpC, Y150F, was reversibly denatured. It was 0.7 kcal/mol (deltaTm = -1.3 degrees C) less stable than wild-type (WT) by thermal denaturation. Both the cloxacillin and the moxalactam adducts with Y150F were significantly destabilized relative to their WT counterparts, suggesting that this residue plays a role in recognizing the acylated intermediate of the beta-lactamase reaction. Reversible denaturation allows for energetic analyses of the complementarity of AmpC for beta-lactams, through ligand binding, and for itself, through residue substitution. Reversible denaturation may be a useful way to study ligand complementarity to other beta-lactam binding proteins as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493583      PMCID: PMC2144403          DOI: 10.1110/ps.8.9.1816

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

1.  5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.

Authors:  M Ishiguro; R Tanaka; K Namikawa; T Nasu; H Inoue; T Nakatsuka; Y Oyama; S Imajo
Journal:  J Med Chem       Date:  1997-07-04       Impact factor: 7.446

2.  Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity.

Authors:  A Morton; B W Matthews
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

3.  Role of asparagine 152 in catalysis of beta-lactam hydrolysis by Escherichia coli AmpC beta-lactamase studied by site-directed mutagenesis.

Authors:  A Dubus; S Normark; M Kania; M G Page
Journal:  Biochemistry       Date:  1995-06-13       Impact factor: 3.162

4.  Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of a beta-lactamase.

Authors:  J Rahil; R F Pratt
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

5.  Evaluating contribution of hydrogen bonding and hydrophobic bonding to protein folding.

Authors:  C N Pace
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding.

Authors:  J K Myers; C N Pace; J M Scholtz
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

7.  Structure-activity studies of the inhibition of serine beta-lactamases by phosphonate monoesters.

Authors:  N Li; J Rahil; M E Wright; R F Pratt
Journal:  Bioorg Med Chem       Date:  1997-09       Impact factor: 3.641

8.  Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.

Authors:  E Lobkovsky; E M Billings; P C Moews; J Rahil; R F Pratt; J R Knox
Journal:  Biochemistry       Date:  1994-06-07       Impact factor: 3.162

9.  Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.

Authors:  G S Weston; J Blázquez; F Baquero; B K Shoichet
Journal:  J Med Chem       Date:  1998-11-05       Impact factor: 7.446

10.  Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.

Authors:  K C Usher; L C Blaszczak; G S Weston; B K Shoichet; S J Remington
Journal:  Biochemistry       Date:  1998-11-17       Impact factor: 3.162

View more
  15 in total

1.  Structural basis for imipenem inhibition of class C beta-lactamases.

Authors:  Beth M Beadle; Brian K Shoichet
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.

Authors:  Alexandra A Bouza; Hollister C Swanson; Kali A Smolen; Alison L VanDine; Magdalena A Taracila; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Robert A Bonomo; Rachel A Powers; Bradley J Wallar
Journal:  ACS Infect Dis       Date:  2017-12-08       Impact factor: 5.084

3.  Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.

Authors:  B M Beadle; R A Nicholas; B K Shoichet
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

4.  Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.

Authors:  Yu Chen; Brian Shoichet; Richard Bonnet
Journal:  J Am Chem Soc       Date:  2005-04-20       Impact factor: 15.419

Review 5.  Why Proteins are Big: Length Scale Effects on Equilibria and Kinetics.

Authors:  Kenneth A Rubinson
Journal:  Protein J       Date:  2019-04       Impact factor: 2.371

6.  Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance.

Authors:  Andrea M Hujer; Christopher R Bethel; Magdalena A Taracila; Steven H Marshall; Laura J Rojas; Marisa L Winkler; Ronald E Painter; T Nicholas Domitrovic; Richard R Watkins; Ayman M Abdelhamed; Roshan D'Souza; Andrew R Mack; Richard C White; Thomas Clarke; Derrick E Fouts; Michael R Jacobs; Katherine Young; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

7.  Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.

Authors:  Marisa L Winkler; Elizabeth A Rodkey; Magdalena A Taracila; Sarah M Drawz; Christopher R Bethel; Krisztina M Papp-Wallace; Kerri M Smith; Yan Xu; Jeffrey R Dwulit-Smith; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Focco van den Akker; Robert A Bonomo
Journal:  J Med Chem       Date:  2013-02-04       Impact factor: 7.446

8.  Protein Stability Effects in Aggregate-Based Enzyme Inhibition.

Authors:  Hayarpi Torosyan; Brian K Shoichet
Journal:  J Med Chem       Date:  2019-10-17       Impact factor: 7.446

9.  Structural bases for stability-function tradeoffs in antibiotic resistance.

Authors:  Veena L Thomas; Andrea C McReynolds; Brian K Shoichet
Journal:  J Mol Biol       Date:  2009-11-10       Impact factor: 5.469

10.  Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam.

Authors:  Cole L Slater; Judith Winogrodzki; Pablo A Fraile-Ribot; Antonio Oliver; Mazdak Khajehpour; Brian L Mark
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.